In order to determine the inter-cyclic effect of oxytocin and carbetocin on equine myometrial tissue, the effect of the drugs was evaluated through pharmacokinetic and pharmaco-dynamic studies. The complete pharmacokinetic profile for oxytocin was unknown and had to be established. To do so, 25 IU of oxytocin were administered intravenously to six cycling mares and blood samples were collected before and 2, 4, 8, 2 and 15 min after administration. The half-life of oxytocin was determined to be 5.89 min, the clearance rate 11.67 l/min, MRT 7.78 min, T max 2 min, and C max 0.51 ng/ml. The effective plasma concentration was estimated to be 0.25 ng/ml. This was similar to the concentration achieved for the organ bath study where the EC 50 was calculated at 0.45 ng/ml. To determine the inter-cyclic effect of oxytocin and carbetocin uterine myometrial samples were collected from slaughtered mares in oestrus, dioestrus and anoestrus. The samples were mounted in organ baths and exposed to four ascending, cumulative doses of oxytocin and carbetocin. Area under the curve and amplitude, E max and EC 50 were studied for each agonist and statistically evaluated. The effect of oxytocin on equine myometrial tissue was higher during dioestrus, and surprisingly anoestrus, than during oestrus, whereas the effect of carbetocin was the same independent of the stage of oestrous cycle. A significant difference was found for oestrous and anoestrous samples when oxytocin was used but not when carbetocin was used.
Introduction
Two major causes for economic losses in the equine breeding industry are the failure of a mare to conceive or a delay in a mare's re-conception [1, 2] , both of which have shown to be caused mainly by a delayed uterine clearance in association with reduced uterine contractility [2] . Uterine contractions are vital in the transport of sperm through the uterus to the uterotubal junction, as well as for the clearance of sperm after breeding, or of accumulated intrauterine fluids [3] . A large percentage of mares susceptible to endometritis most likely have intrinsic contractile defects in myometrial contractility [4] .
This results in accumulation of intrauterine fluid after breeding, predisposing the mare to persistent mating induced endometritis (PMIE) [4] . In the mare, treatment of PMIE and stimulation of postpartum uterine involution [5] includes the use of oxytocin and natural or synthetic prostaglandin F 2α (PGF 2α ), which aid in promoting uterine clearance.
Oxytocin stimulates uterine contractions, release of arachidonic acid and prostaglandin formation, which in turn enhance uterine contractions by causing membrane depolarization and by increasing the number of gap junctions [6] . Clearance of uterine contents provides a uterine environment suitable for an embryo descending into the uterus, thus improving conception rates.
Both oxytocin and PGF 2α have disadvantages in their application; for example, oxytocin needs to be given in short intervals because of it's short half-life (6.8 min.), and PGF 2α in it's natural form has unwanted side effects (sweating, tachypnea, increased gastrointestinal motility, signs of colic) [7, 8] . A drug without side effects and a long half-life stimulating a prolonged tocolytic effect might improve uterine clearance. The 4 use of carbetocin, a long acting analogue of oxytocin, has been investigated as a beneficial form of treatment on uterine involution in bovines [9] , as well as in humans for the treatment of postpartum haemorrhage [10, 11, 12] . In adult, non-lactating anoestrous mares carbetocin has been shown to have a half-life of approximately 17 min., which is 2.5-fold longer than that of oxytocin, and not associated with any side effects [7] . As such we believe that carbetocin may prove more beneficial in horses in inducing parturition, decreasing the time to conception post-partum, and aid in the treatment of PMIE [13] .
For the current study we investigated if the concentration-dependent contractile responses of carbetocin in healthy oestrous, dioestrous and anoestrous equine myometrial smooth muscle were superior to that of oxytocin. The duration of effect was extrapolated from the pharmacokinetic time versus concentration profile for the mentioned oxytocin (selfgenerated) and carbetocin [7] .
Materials and Methods

Pharmacokinetic Study
The pharmacokinetics of oxytocin was evaluated following a single intravenous dose in adult horses.
Animals
Six healthy, adult, non-lactating cycling Nooitgedacht mares of the Veterinary Faculty 5 were used for the study. All animals were vaccinated and dewormed, and kept in their usual environment. The study was approved by the Animal Use and Care Committee of the University of Pretoria according the South African standard for the care of laboratory animals (SANS 10386, Project number V026/08).
Sample collection and Preparation
An indwelling intravenous catheter was placed into the left jugular vein for blood Following collection, the blood samples were centrifuged at 1600 g at 4 °C for 15 min and the supernatant of each sample was transferred to a labelled polycarbonate tube and immediately frozen at -80 °C. Hormone assay samples were extracted using a 200 mg C18 Sep-Pak column under the following conditions: equilibration of the column with 1 ml of acetonitrile, followed by 10-25 ml of 0.1% trifluoroacetic acid (TFA) in water prior to application of the sample. After sample application, the sample was washed with 10-20 ml of 0.1% TFA in water, followed by a final elution with 3 ml of acetonitrile 0.1% TFA in water (60:40). Samples were subsequently dried under a steady stream of nitrogen at 40°C. The half-life (t 1/2 ), mean residence time (MRT), volume of distribution (l/kg) and clearance (ml/kg/min) were calculated using standard formulae. A uterine swab was taken from each mare and the smear examined for uterine pathology, such as the presence of neutrophils and bacteria indicating uterine inflammation. A full thickness uterine biopsy was taken from each mare for histopathology and evaluated according to Kenney [14] . This system takes into consideration inflammation and fibrosis of the endometrium and provides an estimation of the mare's ability to conceive and maintain a pregnancy until term. The uterus was graded from Grade I, IIA, IIB to III.
Mares with a Grade I have a more than 80% chance of conceiving and maintaining a pregnancy until term whereas mares with a Grade III are expected to only have a 10-50% of conceiving and maintaining a pregnancy until term. Only mares without uterine pathology and an endometrial biopsy score of I and IIA were included in the study.
Preparation of smooth muscle specimen
Following transportation to the laboratory, the 32 tissue samples were sectioned into 5 x 20 mm strips in warmed oxygenated KHS. All the prepared strips were full thickness and cut parallel to the longitudinal muscle fibres. The endometrium and any excess connective tissue were dissected apart from the muscle layers using a dissecting microscope.
Tissue baths
The 32 tissue samples were mounted in standard 100 ml organ baths. Each bath was filled with 50 ml of KHS, maintained at 37 °C and continuously bubbled with carbogen.
A force-displacement transducer attached to a chart recorder was used to evaluate the mechanical activity of the myometrium. Time from collection to tissue mounting was approximately 90 to 100 min. Tissue strips were allowed to equilibrate for 30 min prior to tension being applied. Tissues were subsequently mounted under tension of two grams [15] , where after they were exposed to another 15 min of equilibration prior to initial stimulation. Tissues were allowed 2 minutes to contract before ascension to the next dose. After the response to the additive last concentration was recorded, the compound was washed from the organ bath three times, before the subsequent assays were run. The tissues returned to their normal resting phase after the washes and the experiment was continued. Needed electrolytes were supplied in the Buffer solution to avoid depletion of electrolytes. The tissues were given time to equilibrate between responses to return to no or initial contractility.
Data analysis
The amplitudes of the myometrial contractile activity were converted to % response 10 according the following equation: % response = amplitude achieved after exposure/highest amplitude achieved (all samples) multiplied by 100. The maximum response (E max ) and the concentration that produced 50% of the maximum effect (EC 50 ) were ascertained by curve fitting the dose response data to an E max equation (Kinetica 5, Thermo). EC 50 is the concentration required to produce 50% of the response and can be used for comparison between drugs to the nature of the linear nature of PD graphs from 20 to 80%. The E max is theoretically the concentration required to produce a maximum effect and is based on curve fitting. Due to the sigmoid nature of OD curves the E 50 is never related in a linear manner to Emax. The difference in response for the various cycles was evaluated using an ANOVA with Tukey HSD and Bonferroni post-hoc test.
Statistical analysis was performed with the statistical software SPSS19 (IBM). A Kolmogorov-Smirnov and Lilliefors table was used to assess the normality of distribution following various transformations. Since normality could not be demonstrated, differences per treatment for the different cycles were compared with a Kruskal Wallis test and a p-value of 0.05 Post-hoc comparison were made between the cycles using a Mann-Whitney test with the p-value being set at 0.025 following Bonferroni correction.
Differences between the different treatments per cycle were compared using a MannWhitney test at a p-value of 0.05.
Results
Pharmacokinetic study
The plasma versus time concentration profile obtained for oxytocin during the study is 11 presented in Figure 1 . The calculated pharmacokinetic parameters are presented in Table   1 . Comparison between oxytocin and carbetocin during the different cycle stages revealed a significant difference for anoestrus (p=0.031) but no significant difference for oestrus and dioestrus. The mean relative response of carbetocin shows a dose dependent increase up to Conc. 2, were after the effect plateaus.
Discussion
In order to determine the inter-cyclic effect of carbetocin and oxytocin, the effect of the drugs was evaluated through pharmacokinetic and pharmaco-dynamic studies. The effects of both drugs in organ baths were evaluated. To determine the validity of the results, the EC 50 's obtained were compared to estimated effective plasma concentration.
Since the complete pharmacokinetic profile for oxytocin was unknown the first part of modelling was to establish the pharmacokinetics of oxytocin. For the current study the half-life of oxytocin in cycling, non-pregnant mares was determined to be 5.89 minutes, which differed minimally from the half life of 6.8 min reported by Paccamonti et al. [23] .
The difference in the half-life of the two studies most likely results from the different animals used in the two studies (Warmblood mares vs. Nooitgedacht mares) as the difference in body weight and metabolic capacity might affect the clearance rate and the half-life of the drug. This result is supported by other pharmacokinetic studies on oxytocin in farm animals, where a half-life of 22.3 min was reported in goats while the half-life in cattle, from various studies, was approximately 7 to 9 min [24, 25, 26, 27] . As can be seen from this study, there is an inverse proportional relationship between bodyweight and the half-life of response i.e. the smaller animal being the goat having the longer half-life. Another interesting feature of oxytocin is that its metabolism appears to be largely extra-hepatic. Mitchell and co-workers found that rat uterine tissue contains peptidase activity which degrades, metabolizes and thus inactivates oxytocin. They speculated that this mechanism could be important in regulating the metabolism of oxytocin during parturition [28] .
As expected oxytocin was characterised by a low mean residence time (MRT) and a high mean volume of distribution (Vd). Since MRT represented approximately 63% of total time any drug spends in the body, the small value obtained for this study was clearly related to the rapid half-life of the drug. As an estimate the MRT was inversely proportional to the elimination constant. The same principle may be applied to the Vd.
The Vd was determined from the dose being administered against the maximum plasma concentration after intravenous administration. Since the maximum concentration achievable was clearly related to half-life, the rapid elimination did result in a falsely elevated Vd. However, another factor that most likely contributed to the high Vd was the ability of oxytocin to be highly tissue-bound and metabolised in the biophase where it was active [28] at the level of oxytocin receptor.
In order to determine the validity of the results achieved from the ex vivo study, the results were evaluated using pharmacokinetic-pharmacodynamic modelling.
The use of ex vivo techniques to study uterine contractility permits the evaluation of specific contractile responses in tissues obtained from animals of precisely known in vivo functional status in the absence of potentially confounding interactions that might occur in vivo [16] . Ex vivo studies on smooth muscle strips in organ baths have served as an alternative for investigations of myometrial activity. The ex vivo assessment of the contractility of the smooth muscle layer of the uterus in the mare may serve as a more precise and accurate measurement for understanding the influence and interaction of endogenous and exogenous drugs under in vivo conditions [17, 15] . For this study, the effect of the selected agonists on the myometrium alone was determined, as this tissue contains the receptor series involved with contractility.
During the initial part of the experiment, spontaneous contraction of equine myometrial tissue could be observed in only 14 out 32 samples (44%). This was markedly different to a study by Hirsbrunner and co-workers [15] , who were able to demonstrate spontaneous myometrial contractions of all oestrous and dioestrous circular and longitudinal myometrial tissue samples, whereas Rigby and co-workers [17] were "seldom" able to,
while Ousey et al. [18] were not able to demonstrate any spontaneous myometrial contractions. This tends to suggest that the response of the myometrium is dependent on a number of factors such as survivability of tissue ex vivo, number of active receptors, muscle activity and individual variation.
The EC 50 (amount of drug necessary to achieve 50% of maximal contraction) was found to be highest in oestrous tissues, lower in dioestrous tissues, and lowest in anoestrous myometrial tissues after oxytocin administration. Although the EC 50, due to the sigmoid nature of OD curves, is not related in a linear manner to E max the effect on oestrous tissue is unexpected as the results do not follow clinical responses for the drug. The high EC 50 of oestrous tissue suggests that an increased amount of oxytocin is needed in order to cause a response of the myometrium. Expected was that , due to a high concentration of oxytocin receptors within the myometrium during oestrus, a decreased amount of oxytocin is needed to result in a myometrial response, as suggested by literature [21] .
One explanation may involve the rapid metabolism at the level of the endometrium. This mechanism was not considered important for this study, as the endometrium was removed prior to tissue incubation. A second explanation may involve the concentration of active receptors at the level of the muscles. In studies by Tetzke et al. [19] , it was clearly demonstrated that the myometrium receptivity for oxytocin depends on the cycle stage. Further studies by Stull and Evans [20] and Sharp et al. [21] have demonstrated that the oxytocin receptors are present to a greater extent in the myometrium than in the endometrium of non-pregnant and pregnant mares. Receptor numbers have also been shown to differ within the oestrous cycle itself as the highest concentration of receptors can be found during early oestrus (day 14 to 17), compared to late oestrus (day 18 to 0), and dioestrus (day 1 to 13) [21] . The oestrous tissue used in this study had been collected from mares in advanced oestrus (day 18 to 0) during which the receptor number has found to be lower than in early oestrus, increasing the EC 50 to some degree. It arises the question if a higher receptor concentration will result in a higher response, and how will this be evident in the animal in vivo? During an ex vivo study no inhibitory systems are in place as would be in vivo, which might infuence the results. No literature could be found with regards to the response of myometrial tissue to oxytocin during anoestrus. It is surprising that anoestrous myometrial tissue should have a significantly lower EC 50 than oestrous and dioestrous tissue and thus a higher response to oxytocin, assumingly due to a higher oxytocin receptor concentration. These results can currently not be explained and need further investigation.
In contrast, myometrial contractility in response to carbetocin did not appear to be affected by the stage of the cycle. The reason for the lack of a stage related response by carbetocin is more difficult to explain. One reason for the effect seen may be due to a difference in receptor binding between oxytocin and carbetocin. The first receptor mechanism results from the direct stimulation of the myometrium via a vasopressin receptor with subsequent activation of a calcium controlling second messenger system [22] . The second receptor mechanism relies on the stimulation of oxytocin receptors in 20 the endometrium and myometrium with subsequent release of PGF 2α and its related stimulation of uterine contractions and luteolysis [22] . Of these two receptor series the oxytocin receptor is cyclic (as mention above) in their concentration while the vasopressin receptor remains at a constant level [22] . In a study by Engstrom et al. [22] it was further demonstrated that oxytocin had poor affinity for the vasopressin receptor while carbetocin had affinity for both receptor series. This would therefore explain the differences evident i.e. the effect of oxytocin being cyclic due to cyclic activation of the receptor while carbetocin is able to produce a constant effect due to the constant concentration and presence of the vasopressin receptors system [22] .
Based on the pharmacokinetic profile for oxytocin and the known effective duration of 6.8 min for the non-pregnant mare, the effective plasma concentration is estimated to be 0.25 ng/ml. This was similar to the concentration achieved for the organ bath study where the lowest EC 50 was calculated at 0.45 ng/ml for anoestrous mares. When the same trend is applied to the published carbetocin pharmacokinetic information, and the effective duration of 17 min, the effective plasma concentration was estimated to be 3 ng/ml. This was once again familiar to the lowest EC 50 of 3.47 ng/ml in anoestrous mares. This therefore tends to suggest that the organ bath concentrations are relevant to the adult horse.
Conclusion
The results suggest that the effect of oxytocin on equine myometrial tissue is higher during dioestrus, and surprisingly anoestrus, than during oestrus, whereas the effect of carbetocin seems to be the same independent of the stage of oestrous cycle. An 21 advantage of carbetocin is its longer half-life (17 min) over the half-life of oxytocin (6 min) in the mare.
These results might be useful in the treatment of uterine pathology, such as advanced stages of PMIE, pyometra as well as for induction or enhancement of myometrial contractions during parturition.
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